KR20220066595A - Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients - Google Patents
Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients Download PDFInfo
- Publication number
- KR20220066595A KR20220066595A KR1020200152797A KR20200152797A KR20220066595A KR 20220066595 A KR20220066595 A KR 20220066595A KR 1020200152797 A KR1020200152797 A KR 1020200152797A KR 20200152797 A KR20200152797 A KR 20200152797A KR 20220066595 A KR20220066595 A KR 20220066595A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- hair
- hair loss
- riboflavin
- leaf extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229960002477 riboflavin Drugs 0.000 title claims abstract description 39
- 235000019192 riboflavin Nutrition 0.000 title claims abstract description 36
- 239000002151 riboflavin Substances 0.000 title claims abstract description 36
- 239000002537 cosmetic Substances 0.000 title claims abstract description 33
- 239000000284 extract Substances 0.000 title claims abstract description 25
- 230000003658 preventing hair loss Effects 0.000 title claims abstract description 25
- 239000004480 active ingredient Substances 0.000 title claims abstract description 8
- 244000061520 Angelica archangelica Species 0.000 title abstract description 3
- 235000007070 Angelica archangelica Nutrition 0.000 title abstract description 3
- 230000003779 hair growth Effects 0.000 claims abstract description 12
- 241000125175 Angelica Species 0.000 claims description 21
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 16
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 210000004209 hair Anatomy 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 210000004761 scalp Anatomy 0.000 description 20
- -1 for example Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 201000004384 Alopecia Diseases 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000003676 hair loss Effects 0.000 description 7
- 208000024963 hair loss Diseases 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 239000003708 ampul Substances 0.000 description 3
- 239000001180 angelica archangelica l. root extract Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000003646 hair health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001656769 Lilium canadense Species 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000003700 hair damage Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940023735 panthenyl ethyl ether Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 230000037152 sensory function Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 리보플라빈(RIBOFLAVIN)과 안젤리카잎추출물(ANGELICA ARCHANGELICA LEAF EXTRACT)을 유효성분으로 포함하는 탈모 방지용 화장료 조성물로서, 헤어 용품 본연의 기능을 감소 시키지 않으면서 탈모를 방지하고 두피를 보호함과 동시에 두피의 혈액순환을 자극하여 발모를 촉진시킬 수 있는 탈모 방지용 화장료 조성물에 관한 것이다. The present invention is a cosmetic composition for preventing hair loss comprising RIBOFLAVIN and ANGELICA ARCHANGELICA LEAF EXTRACT as active ingredients. It relates to a cosmetic composition for preventing hair loss that can promote hair growth by stimulating blood circulation of
Description
본 발명은 리보플라빈 및 안젤리카잎추출물을 유효성분으로 포함하는 탈모 방지용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for preventing hair loss comprising riboflavin and angelica leaf extract as active ingredients.
사회의 발달에 따른 환경적인 요인과 사회적인 요인 등 다양한 원인요소들에 의해 다양한 연령층 및 여성에게서도 탈모의 증상이 증가하고 있는 추세이다. 이와 같은 탈모 현상은 환경 및 사회적인 요인에 의한 것으로, 특히 잦은 퍼머, 염색, 스트레스, 심한 다이어트등으로 인하여 최근에는 남성에게만 국한되지 않고 여성에게서도 그 증상 발생률이 증가하고 있는 추세이며 발생 연령 또한 점차 낮아지고 있다. 두피는 근본적으로 체내의 모든 기관을 기계적 외력, 화학적 독물의 침해, 미생물의 침입, 일광 등의 외적 환경으로부터 보호기능과 흡수작용, 호흡 및 배설의 작용, 감각 기능을 갖는다. 이러한 두피는 체내의 유해물질과 노폐물들을 배설하기도 하는데, 두피에 각질 및 노폐물들이 피지와 섞여 표면에 쌓이게 되면, 두피 모공을 막아, 피부 호흡을 막고, 두피에 염증을 발생시키기도 하고, 모발이 가늘어지게 된다. 피부 호흡이 원활하지 못하게 되면, 체내에 축적되어 결국에 신체 균형을 흩뜨리게 되어 다른 기능에도 막대한 영향을 끼쳐 이상 두피 현상이 생기기도 한다.Due to various causal factors such as environmental and social factors according to the development of society, symptoms of hair loss are increasing in various age groups and women as well. This hair loss phenomenon is caused by environmental and social factors. In particular, due to frequent perming, dyeing, stress, and severe diet, the incidence rate of the symptoms is increasing not only in men but also in women in recent years, and the age of occurrence is also gradually decreasing. have. The scalp basically protects all organs in the body from external environments such as mechanical external forces, chemical poisons, invasion of microorganisms, sunlight, etc., and has functions of absorption, respiration and excretion, and sensory functions. The scalp also excretes harmful substances and wastes from the body. When dead skin cells and waste products are mixed with sebum on the scalp and accumulate on the surface, they block the scalp pores, prevent skin respiration, cause inflammation in the scalp, and cause hair thinning. do. If the skin does not breathe smoothly, it accumulates in the body and eventually disturbs the body's balance, which has a huge effect on other functions, leading to abnormal scalp phenomenon.
모발의 세척을 위해 일반적으로 비누 또는 샴푸가 많이 사용되고 있으며, 특히 최근에는 일반 소비자의 모발의 건강에 대한 관심도가 높아짐에 따라 단순한 세척만이 아니라 두피와 모발의 건강을 통한 탈모를 예방하기 위한 기능성 샴푸에 대한 개발이 활발히 전개되고 있는 추세이다. 또한, 실제 생활 속에서 샴푸 등 모발용 화장품류를 70% 이상 사용하고 있고, 의약 외용품까지 포함할 경우 80% 이상을 차지하여 생활에 유용한 건강한 샴푸의 개발은 중요하다 할 것이다.In general, soap or shampoo is used a lot for washing hair, and in particular, in recent years, as general consumers' interest in hair health has increased, functional shampoo for preventing hair loss through not only simple washing but also scalp and hair health. development is being actively pursued. In addition, in real life, more than 70% of hair cosmetics such as shampoo are used, and when external pharmaceuticals are included, it accounts for more than 80%, so it is important to develop a healthy shampoo useful for life.
한국등록특허 제10-1310970호는 황련, 황백, 황금 등을 포함하는 제1 탈모방지용 한방 추출물 및 우방자, 방풍 등을 포함하는 제2 탈모방지용 한방추출물을 포함하는 헤어용품 조성물에 관하여 개시되어 있다.Korean Patent No. 10-1310970 discloses a hair product composition comprising a first anti-hair loss oriental herbal extract containing yellow lily, yellow white, golden, and the like, and a second anti-hair loss, oriental herbal extract, including woobangja, windbreak, and the like.
본 발명의 목적은 샴푸, 헤어컨디셔너 또는 헤어에센스와 같은 헤어용품 본연의 기능을 감소시키지 않으면서 리보플라빈과 안젤리카잎추출물을 혼합 사용할 경우 시너지 효과를 발휘하며 탈모를 방지하고 동시에 두피의 혈액순환을 자극하여 발모를 촉진시키는 화장료 조성물을 제공하는 것이다An object of the present invention is to exert a synergistic effect when using a mixture of riboflavin and angelica leaf extract without reducing the original function of hair products such as shampoo, hair conditioner or hair essence, and prevent hair loss and at the same time stimulate blood circulation of the scalp. To provide a cosmetic composition that promotes hair growth
상기한 목적을 달성하기 위하여, 본 발명은 리보플라빈 및 안젤리카잎추출물을 유효성분으로 포함하는 탈모 방지용 화장료 조성물을 제공한다. In order to achieve the above object, the present invention provides a cosmetic composition for preventing hair loss comprising riboflavin and angelica leaf extract as active ingredients.
바람직하게는 상기 리보플라빈은 화장료 조성물의 전체 중량에 대하여 0.00001 ~ 0.006 중량%로 포함될 수 있다.Preferably, the riboflavin may be included in an amount of 0.00001 to 0.006% by weight based on the total weight of the cosmetic composition.
또한 바람직하게는, 상기 안젤리카잎추출물은 화장료 조성물의 전체 중량에 대하여 0.1 ~ 60.0 중량%로 포함될 수 있다.Also preferably, the angelica leaf extract may be included in an amount of 0.1 to 60.0% by weight based on the total weight of the cosmetic composition.
또한 바람직하게는, 상기 화장료 조성물은 발모를 촉진하며 탈모를 방지하는 효과를 갖는다.Also preferably, the cosmetic composition has the effect of promoting hair growth and preventing hair loss.
또한 바람직하게는, 상기 리보플라빈 및 안젤리카잎 추출물은 1: 10,000~40,000 의 중량비로 혼합되어 포함될 수 있다. Also preferably, the riboflavin and angelica leaf extract may be mixed and included in a weight ratio of 1: 10,000 to 40,000.
본 발명에 따른 리보플라빈 및 안젤리카잎추출물을 포함하는 탈모 방지용 화장료 조성물은, 두피 및 모근 주위의 혈액순환을 개선시켜 탈모를 방지하는 동시에 두피를 건강하게 유지할 수 있으며 모발에 영양분을 제공하여 발모가 촉진되는 탁월한 효과가 있다. 또한, 본 발명에 따른 탈모 방지용 화장료 조성물은, 종래의 헤어용품보다 두피의 자극을 완화시켜 탈모를 방지하는 효과가 있으며, 두피치유 및 발모촉진에 탁월한 효능을 발휘하는 탈모방지용 리보플라빈과 안젤리카잎추출물이 첨가됨에 따라 두피 및 모근 주위의 혈액순환이 개선되어 탈모가 방지됨과 동시에 두피가 건강하게 유지될 수 있으며 모발에 영양분이 제공되어 발모가 촉진되는 탁월한 효과가 있다.The cosmetic composition for preventing hair loss comprising riboflavin and angelica leaf extract according to the present invention can prevent hair loss by improving blood circulation around the scalp and hair root, and at the same time keep the scalp healthy, and provides nutrients to the hair to promote hair growth It has an excellent effect. In addition, the cosmetic composition for preventing hair loss according to the present invention has the effect of preventing hair loss by alleviating stimulation of the scalp compared to conventional hair products, and contains riboflavin and angelica leaf extract for preventing hair loss that exhibits excellent efficacy in scalp healing and hair growth promotion. As it is added, blood circulation around the scalp and hair roots is improved, hair loss is prevented, the scalp can be kept healthy, and nutrients are provided to the hair to promote hair growth.
본 발명에서 사용되는 모든 기술용어는, 달리 정의되지 않는 이상, 하기의 정의를 가지며 본 발명의 관련 분야에서 통상의 당업자가 일반적으로 이해하는 바와 같은 의미에 부합된다. 또한, 본 명세서에는 바람직한 방법이나 시료가 기재되나, 이와 유사하거나 동등한 것들도 본 발명의 범주에 포함된다. 본 명세서에 참고문헌으로 기재되는 모든 간행물의 내용은 본 발명에 도입된다. 용어 약이라는 것은 참조 양, 수준, 값, 수, 빈도, 퍼센트, 치수, 크기, 양, 중량 또는 길이에 대해 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2 또는 1% 정도로 변하는 양, 수준, 값, 수, 빈도, 퍼센트, 치수, 크기, 양, 중량 또는 길이를 의미한다.All technical terms used in the present invention, unless otherwise defined, have the following definitions and have the meanings as commonly understood by one of ordinary skill in the art of the present invention. In addition, although preferred methods and samples are described herein, similar or equivalent ones are also included in the scope of the present invention. The contents of all publications herein incorporated by reference are incorporated herein by reference. The term about means 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, means an amount, level, value, number, frequency, percentage, dimension, size, amount, weight or length varying by 3, 2 or 1%.
본 명세서를 통해, 문맥에서 달리 필요하지 않으면, "포함하다" 및 "포함하는"이란 말은 제시된 단계 또는 구성요소, 또는 단계 또는 구성요소들의 군을 포함하나, 임의의 다른 단계 또는 구성요소, 또는 단계 또는 구성요소들의 군이 배제되지는 않음을 내포하는 것으로 이해하여야 한다.Throughout this specification, unless the context requires otherwise, the terms "comprises" and "comprising" include, but are not limited to, a given step or element, or group of steps or elements, but any other step or element, or It is to be understood that a step or group of elements is not excluded.
본 발명자들은 피부노화를 방지하는 물질을 검색하기 위하여 여러가지 성분을 대상으로 연구한 결과, 신체 신진대사에 중요한 역할을 수행하는 리보플라빈과 안젤리카잎추출물을 혼합 사용시 탈모방지에 효과가 크다는 것을 알게 되어 본 발명을 완성하게 되었다. As a result of research on various components to search for substances that prevent skin aging, the present inventors have found that the combination of riboflavin and angelica leaf extract, which plays an important role in body metabolism, is effective in preventing hair loss. was completed.
본 발명은 리보플라빈 및 안젤리카잎추출물을 유효성분으로 포함하는 탈모 방지용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for preventing hair loss comprising riboflavin and angelica leaf extract as active ingredients.
리보플라빈(riboflavin; 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; 7,8-dimethyl-10-ribitylisoalloxazine)은 비타민 B2로 알려져 있는 수용성 비타민의 일종이며 락토플라빈(lactoflavine)으로도 불린다. 분자식은 C17H20N4O6, 분자량은 376.36 이며 278-282 °C에서 분해되는 특성을 갖고 아래 화학식 1의 구조를 갖는다. 플라빈은 라틴어로 노란색을 의미하며 실제로도 수용액은 노란색이고, 무수 상태의 리보플라빈 가루는 주황색을 띠고 있다. 리보플라빈은 탄수화물과 아미노산의 산화와 관련된 물질 대사에 관여하는 것으로 알려져 있다. 우유, 달걀, 동물의 간 등에 풍부하게 존재하며 성인의 경우 매일 1.2~1.7 ㎎의 비타민 B2를 필요로 한다. 대장 내 세균에 의해서도 자체적으로 상당량의 비타민 B2가 합성되고 있다. 따라서, 이러한 다양한 기능을 가진 리보플라빈을 포함하는 본 발명의 탈모방지용 헤어 조성물은 모유두세포(dermal papilla cells)의 활성화를 높일 뿐만 아니라 혈액 순환을 높여 탈모 방지에 우수한 효과를 부여할 수 있다. Riboflavin (7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; 7,8-dimethyl-10-ribitylisoalloxazine) is a type of water-soluble vitamin known as vitamin B2. Also called lactoflavin. The molecular formula is C17H20N4O6, the molecular weight is 376.36, and it has the property of being decomposed at 278-282 °C and has the structure of Formula 1 below. Flavin means yellow in Latin, and the aqueous solution is actually yellow, and the anhydrous riboflavin powder has an orange color. Riboflavin is known to be involved in metabolism related to oxidation of carbohydrates and amino acids. It is abundantly present in milk, eggs, and liver of animals. Adults require 1.2 to 1.7 mg of vitamin B2 daily. A significant amount of vitamin B2 is also synthesized by bacteria in the large intestine. Therefore, the hair composition for preventing hair loss of the present invention containing riboflavin having such various functions not only increases the activation of dermal papilla cells but also increases blood circulation, thereby providing an excellent effect in preventing hair loss.
본 발명에서는 리보플라빈은 SIGMA사의 RIBOFLAVIN(EC No. 201-507-1)를 사용하였다. 리보플라빈은 아래 화학식 1의 구조를 갖는다.In the present invention, riboflavin was used by SIGMA's RIBOFLAVIN (EC No. 201-507-1). Riboflavin has the structure of Formula 1 below.
상기 리보플라빈은 화장료 조성물의 전체 중량에 대해서 0.00001 ~ 0.006 중량% 함유되는 것을 특징으로 한다. 상기 추출물의 함량이 0.0001 중량% 미만인 경우에는 탈모 방지 효과가 나타나지 않으며, 0.006 중량%를 초과하는 경우에는 함유량 증가에 대한 탈모 방지 효과 증대 정도가 미미하며, 제형상의 안전 및 안정성에 문제가 있으며 경제적이지도 못하다.The riboflavin is characterized in that it is contained in an amount of 0.00001 to 0.006% by weight based on the total weight of the cosmetic composition. If the content of the extract is less than 0.0001% by weight, the effect of preventing hair loss does not appear, and when it exceeds 0.006% by weight, the degree of increase in the effect of preventing hair loss with respect to the increase in the content is insignificant, and there is a problem in safety and stability in the formulation and economy. not even an enemy
안젤리카(Angelica archangelica)는 유럽 원산의 산형과의 식물로, '천사'를 의미하는 'angelus'라는 단어에서 유래되었는데, 본 속의 식물 중에 강심제적 효과가 있는 것이 있어 죽은 사람을 소생시킬 수 있다는데서 유래되었다. 안젤리카의 방향이 있는 쓴맛은 위장에 대단히 좋으며 소화 불량, 복통, 산통, 고창을 완화하는 것으로 알려져 있고, 소화기관을 자극하고 따뜻하게 하는 작용이 있다. 또한, 안젤리카는 혈액 순환을 촉진시켜 빈혈에도 효과가 있고, 항균 작용과 항진균 작용을 하는 것으로 확인된 바 있다.Angelica (Angelica archangelica) is a plant of the umbel family, native to Europe, and is derived from the word 'angelus' meaning 'angel'. became The aromatic bitter taste of angelica is very good for the stomach and is known to relieve indigestion, abdominal pain, colic, flatulence, and has a stimulating and warming effect on the digestive system. In addition, angelica promotes blood circulation and is effective in anemia, and has been confirmed to have antibacterial and antifungal actions.
본 발명의 안젤리카 추출물은 당업계에 공지된 액체 질소를 이용한 냉각 추출법의 통상적인 방법에 따라, 즉, 통상적인 온도와 압력의 조건 하에서, 통상적인 용매를 사용하여 제조될 수 있다. 바람직하게는 물, 탄소수 1-4의 무수 또는 함수 저급 알코올 (예를들면, 메탄올, 에탄올, 프로판올 및 부탄올), 프로필렌글리콜, 1,3-부틸렌글리콜, 글리세린, 아세톤, 디에틸에테르, 에틸 아세테이트, 부틸아세테이트, 디클로로메탄, 클로로포름, 헥산 및 이들의 혼합물로 구성된 군으로부터 선택되는 1종 이상의 추출 용매를 사용하여 얻을 수 있다. 보다 바람직하게는 에탄올, 70%(v/v) 에탄올 또는물을 사용하여 얻어진 것이고, 가장 바람직하게는 70%(v/v) 에탄올을 사용하여 얻을 수 있다.The angelica extract of the present invention can be prepared according to a conventional method of cooling extraction using liquid nitrogen known in the art, that is, under conditions of conventional temperature and pressure, using a conventional solvent. Preferably water, anhydrous or hydrous lower alcohols having 1 to 4 carbon atoms (e.g., methanol, ethanol, propanol and butanol), propylene glycol, 1,3-butylene glycol, glycerin, acetone, diethyl ether, ethyl acetate , butyl acetate, dichloromethane, chloroform, hexane, and can be obtained using one or more extraction solvents selected from the group consisting of mixtures thereof. More preferably, it is obtained by using ethanol, 70% (v/v) ethanol or water, and most preferably, it can be obtained by using 70% (v/v) ethanol.
상기 안젤리카잎추출물은 화장료 조성물의 전체 중량에 대하여 0.1 ~ 60.0 중량로 포함될 수 있다. 보다 바람직하게는 화장료 조성물의 전체 중량에 대하여 1.0 ~ 40.0 중량%로 포함될 수 있다.The angelica leaf extract may be included in an amount of 0.1 to 60.0 weight based on the total weight of the cosmetic composition. More preferably, it may be included in an amount of 1.0 to 40.0% by weight based on the total weight of the cosmetic composition.
본 발명의 화장료 조성물은 리보플라빈 및 안젤리카잎 추출물을 1: 10,000~40,000 의 중량비로 포함할 수 있고, 보다 바람직하게는 1:30,000의 중량비로 혼합하여 포함할 수 있다. The cosmetic composition of the present invention may include riboflavin and angelica leaf extract in a weight ratio of 1: 10,000 to 40,000, more preferably, by mixing it in a weight ratio of 1: 30,000.
본 발명의 화장료 조성물에 함유되는 성분은 안젤리카 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 및 담체 등을 포함한다.The components contained in the cosmetic composition of the present invention include components commonly used in cosmetic compositions in addition to the angelica extract, for example, conventional auxiliary agents such as antioxidants, stabilizers, solubilizers, vitamins, pigments and fragrances, and carriers. include
본 발명의 화장료 조성물에 포함되는 성분은 유효 성분으로서 상기 유효 성분 이외에 헤어 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다. 본 발명의 헤어 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 계면활성제-함유 클렌징, 팩, 헤어 마사지크림 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 헤어 토닉, 헤어 영양수, 헤어 마사지 크림, 헤어, 헤어 클렌징 워터, 팩, 스프레이 또는 헤어 샴푸 등에 적용 될 수 있다. The ingredients included in the cosmetic composition of the present invention may include ingredients commonly used in hair cosmetic compositions in addition to the active ingredients as active ingredients, for example, antioxidants, stabilizers, solubilizers, vitamins, pigments, and fragrances. phosphorus adjuvant, and a carrier. The hair cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, a solution, suspension, emulsion, paste, gel, cream, lotion, surfactant-containing cleansing, pack, It may be formulated as a hair massage cream and spray, but is not limited thereto. More specifically, it may be applied to a hair tonic, hair nourishing water, hair massage cream, hair, hair cleansing water, pack, spray or hair shampoo.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연등이 이용될 수 있다. 본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르가 있다. When the formulation of the present invention is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol fatty ester, polyethylene glycol or fatty acid ester of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다. When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, and microcrystals Adult cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다. When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, propane /may contain propellants such as butane or dimethyl ether.
본 발명의 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a cleansing agent containing surfactant, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether as carrier components Sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative or ethoxylated glycerol fatty acid ester may be used.
본 발명의 화장료 조성물이 계면활성제 함유 클렌징 제형 또는 계면활성제 비함유 클렌징 제형일 경우, 모발에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. When the cosmetic composition of the present invention is a surfactant-containing cleansing formulation or a surfactant-free cleansing formulation, it may be applied to the hair and then wiped off, removed, or washed off with water.
본 발명의 리보플라빈 및 분획물을 포함하는 화장료 조성물을 이용하는 화장방법을 수행하면 혈액 순환에 도움을 주어 탈모 방지 효과를 얻을 수 있다. When a cosmetic method using the cosmetic composition comprising riboflavin and a fraction of the present invention is performed, it helps blood circulation and thus prevents hair loss.
이하, 실시예를 들어서 본 발명을 구체적으로 설명한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다.Hereinafter, the present invention will be specifically described with reference to Examples. These examples are only for illustrating the present invention in more detail, and the scope of the present invention is not limited by these examples according to the gist of the present invention.
[실험예 1] [Experimental Example 1]
인간 유래 모유두세포를 10% FBS 및 1% antibiotics(100 units/ml penicillin 및 100 ug/ml streptomycin)를 포함하는 DMEM 배지를 사용하여 배양한다. 3-4번째 세대의 모유두세포를 실험에 사용하여 MTT assay로 모유두세포의 성장 증식 효능을 확인하였다. 96-웰 마이크로플레이트에 1% FBS를 포함하는 DMEM 배지에 모유두세포(1×104 cells/㎖)를 넣고 24시간 전배양하고 제조예로부터 획득한 시료를 여러 농도로 처리한 다음 4일간 배양하였다. 3-[4,5-다이메틸티아졸-2-일]-2,5-다이페닐테트라졸륨 브로마이드(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide(MTT))를 50㎕ 첨가하고 4시간 더 배양한 다음, 원심 분리하여 상층액을 제거하였다. 여기에 다이메틸설폭사이드를 가하여 침전물을 용해시킨 다음 MTT의 환원에 따른 포르마잔 침전물의 생성 정도로 인간유래 모유두세포의 증식 효과를 확인하고 결과를 표 1에 나타내었다.Human-derived dermal papilla cells are cultured using DMEM medium containing 10% FBS and 1% antibiotics (100 units/ml penicillin and 100 ug/ml streptomycin). The effect of growth and proliferation of dermal papilla cells was confirmed by MTT assay using 3rd and 4th generation dermal papilla cells. In a 96-well microplate, dermal papilla cells (1×104 cells/ml) were put in DMEM medium containing 1% FBS, and pre-cultured for 24 hours, and the samples obtained from Preparation Example were treated with various concentrations, and then cultured for 4 days. 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) ) was added and incubated for another 4 hours, and then centrifuged to remove the supernatant. After dissolving the precipitate by adding dimethyl sulfoxide to it, the proliferation effect of human-derived dermal papilla cells was confirmed to the extent of the formation of the formazan precipitate according to the reduction of MTT, and the results are shown in Table 1.
(control 대비)(vs control)
Angelica Herb Extract
+
리보플라빈 Angelica Herbal Extract
+
Riboflavin
(전초) 30 wt% +
리보플라빈 30ppmAngelica Extract
(outpost) 30 wt% +
Riboflavin 30ppm
+
리보플라빈Angelica Root Extract
+
Riboflavin
30 wt% +
리보플라빈 30ppmAngelica Root Extract
30 wt% +
Riboflavin 30ppm
+
리보플라빈Angelica Leaf Extract
+
Riboflavin
30 wt% +
리보플라빈 30ppmAngelica Leaf Extract
30 wt% +
Riboflavin 30ppm
[실험예 2] [Experimental Example 2]
아래 표 2의 조성에 따라 헤어 앰플을 각각 제조한 후, 비듬과 두피가려움증이 있는 사람 10명을 포함하여 각각 25명씩 제 1 그룹과 제 2 그룹으로 나눈 다음, 제 A 그룹에 속하는 25명에게는 리보플라빈이 함유된 헤어 앰플(실시예 1)을 7주(45일)간 사용하게 하고, 제 B 그룹에 속하는 25명에게는 리보플라빈이 함유하지 않은 헤어 앰플과 LED 광 조사를 하지 않고(비교예 1)를 7주간(45일) 사용하게 하였다. 그 결과를 표 3에 나타냈다.After each hair ampoule was prepared according to the composition in Table 2 below, 25 people, including 10 people with dandruff and itchy scalp, were divided into the first and second groups, respectively, and then riboflavin for 25 people belonging to group A. The hair ampoule containing this (Example 1) was used for 7 weeks (45 days), and the hair ampoule without riboflavin and LED light irradiation were not performed (Comparative Example 1) for 25 people belonging to group B. They were allowed to use for 7 weeks (45 days). The results are shown in Table 3.
발모 상태의 경우, 두부 전체에 발모 증상이 있으며 모발 수의 증가 현상이 있다면 '매우 좋음', 두부 일부에 발모 증상이 있으며 두부 일부에서 모발 수의 증가 현상이 있다면 '좋음', 발모 증상이 없는 경우에는 '변화없음'으로 하였고, 모발 영양상태의 경우, 모발 손상 상태가 거의 없고 매끄러운 상태로서 전체적으로 풍부한 경우에는 '매우 좋음', 모발 손상 상태가 일부분에 국한되고 모발이 매끄러운 경우 '좋음', 사용 전과 모발상태 개선이 없는 경우에는 '변화 없음'으로 하였다.두피 상태의 경우에는 두피 전체적으로 피지가 없어지고 가려움증이 없으며 두피가 청결한 상태이면 '매우 좋음', 피지나 가려움증이 일부 개선되어 청결상태가 좋아진 경우에는 '좋음', 사용전과 두피 상태가 변화가 없는 경우에는 '변화 없음'으로 하였다. In the case of hair growth, if there is hair growth on the entire head and there is an increase in the number of hairs, it is 'Very good', if there is hair growth on a part of the head and there is an increase in the number of hair in a part of the head, it is 'good', if there is no symptom of hair growth In the case of hair nutritional status, it was set as 'Very good' if there was little damage to the hair and if the hair was in a smooth and abundant condition, 'Good' if the hair damage was limited to a part and the hair was smooth. If there was no improvement in hair condition, it was set as 'no change'. In the case of scalp condition, if the scalp is completely free of sebum and there is no itching, if the scalp is clean, it is 'Very good', if the sebum or itching is partially improved and the cleanliness is improved. 'Good', and 'No change' if there was no change in scalp condition before use.
상기 표 3에서 확인되는 바와 같이, 리보플라빈을 함유하는 탈모방지용 헤어용품을 조성물을 지속적으로 사용할 경우에는, 55% 이상의 사용자에게 탈모율 감소효과가 나타났으며, 모든 사용자에게 탈모 방지 효과가 나타날 뿐만 아니라, 가는 모발이나 잔털이 굵어지는 효과가 있었다. 또한, 모발 영양 상태는 대부분 좋은 변화가 있었으며 65% 이상 우수한 효과가 있었으며 두피 상태가 대부분 개선되었음을 확인할 수 있었다.As can be seen in Table 3 above, when the composition for preventing hair loss containing riboflavin was continuously used, the effect of reducing the hair loss rate was shown to 55% or more of users, and the effect of preventing hair loss was shown to all users as well. , had the effect of thickening fine hair or fine hair. In addition, it was confirmed that most of the hair nutritional status had a good change, and the effect was excellent by more than 65%, and the condition of the scalp was mostly improved.
이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다. As described above in detail a specific part of the present invention, for those of ordinary skill in the art, this specific description is only a preferred embodiment, and it is clear that the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200152797A KR102527040B1 (en) | 2020-11-16 | 2020-11-16 | Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200152797A KR102527040B1 (en) | 2020-11-16 | 2020-11-16 | Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220066595A true KR20220066595A (en) | 2022-05-24 |
KR102527040B1 KR102527040B1 (en) | 2023-05-02 |
Family
ID=81806115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200152797A Active KR102527040B1 (en) | 2020-11-16 | 2020-11-16 | Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102527040B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102541810B1 (en) * | 2023-01-05 | 2023-06-13 | 한국콜마주식회사 | Compositions for improving skin comprising angelica and cranberry extracts and uses thereof |
IT202300003327A1 (en) * | 2023-02-24 | 2024-08-24 | Giuliani Spa | COMPOSITION TO IMPROVE THE AESTHETIC APPEARANCE OF HAIR AND PROMOTE ITS GROWTH |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070065950A (en) * | 2005-11-25 | 2007-06-27 | (주)아모레퍼시픽 | Composition for promoting hair growth containing vitamin VII group and pyrimidine oxide derivative |
JP2017066145A (en) * | 2016-10-07 | 2017-04-06 | 国立大学法人九州大学 | Hair matrix growth promoter, hair papilla cell growth promoter, alopecia topical medicine and method for producing alopecia topical medicine |
-
2020
- 2020-11-16 KR KR1020200152797A patent/KR102527040B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070065950A (en) * | 2005-11-25 | 2007-06-27 | (주)아모레퍼시픽 | Composition for promoting hair growth containing vitamin VII group and pyrimidine oxide derivative |
JP2017066145A (en) * | 2016-10-07 | 2017-04-06 | 国立大学法人九州大学 | Hair matrix growth promoter, hair papilla cell growth promoter, alopecia topical medicine and method for producing alopecia topical medicine |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102541810B1 (en) * | 2023-01-05 | 2023-06-13 | 한국콜마주식회사 | Compositions for improving skin comprising angelica and cranberry extracts and uses thereof |
IT202300003327A1 (en) * | 2023-02-24 | 2024-08-24 | Giuliani Spa | COMPOSITION TO IMPROVE THE AESTHETIC APPEARANCE OF HAIR AND PROMOTE ITS GROWTH |
WO2024175703A1 (en) * | 2023-02-24 | 2024-08-29 | Giuliani S.P.A. | Composition for improving the aesthetic appearance of hair and skin appendages |
Also Published As
Publication number | Publication date |
---|---|
KR102527040B1 (en) | 2023-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
KR101393007B1 (en) | Cosmetic Composition for Skin-aging Protection and Wrinkle Improvement Comprising the Extract of Nephelium lappaceum and Litchi chinensis sonn as Active Ingredient | |
KR101849924B1 (en) | Composition Having Promoting Effect on Induction of Black Hair and Inhibitory Effect on Induction of White Hair | |
KR101196523B1 (en) | Composition for promoting hair growth comprising fermented oriental medicine extract | |
KR101885199B1 (en) | Cosmetic composition containing the mixed extract of pomegranate, rosa centifolia flower, carthamus tinctorius and rosa rugosa | |
CN107213096A (en) | A kind of plant type suncream and preparation method thereof | |
CN107412031B (en) | Skin external composition containing hesperetin | |
KR101312965B1 (en) | The cosmetic composition for anti-wrinkle comprising the mixture of extract of Allium cepa, Symphytum officinale, Eclipta prostrate, and Theobroma cacao | |
KR101555354B1 (en) | Cosmetic composition using fermented plant and manufacturing method thereof and hair shampoo | |
KR20170065232A (en) | Composition for preventing hair loss comprising extracts of crude drug complex | |
KR101757469B1 (en) | Compositions for promoting hair growth and inhibiting inflammation comprising mixed extracts of natural products | |
KR102527040B1 (en) | Cosmetic composition for preventing hair loss containing riboflavin and angelica archangelica leaf extract as active ingredients | |
KR102293975B1 (en) | Eco shampoo composition comprising hydrogen peroxide and extracts of Ulmus davidiana var. japonica and the preparation method of the same | |
KR102064599B1 (en) | Cosmetic composition for preventing hair loss containing arctium lappa seed extract, niacinamide and methyl pca | |
KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
KR20140145278A (en) | Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect | |
KR20210083236A (en) | Composition for preventing hair loss and improving the scalp | |
KR102789350B1 (en) | Antioxidant, hair root improvement, and hair loss prevention and improvement composition comprising the viola papilionacea extract as an active ingredient, and food and external preparations containing the same | |
KR101969475B1 (en) | Cosmetic compositions for improving skin comprising mixed plant extract with Cirsium japonicum as effective ingradients | |
JP6175216B2 (en) | Preventive and therapeutic agents for arthritis | |
KR100946584B1 (en) | Cosmetic composition for astringent and skin irritation containing fruit extract and Blue Lotus extract | |
KR20090073632A (en) | Cosmetic composition for alleviating skin irritation containing Yeok wood extract and licorice extract | |
KR101743001B1 (en) | Cosmetic composition containing chitosan and propolis extracts | |
KR102496500B1 (en) | Cosmetic composition comprising hydroxydecyl ubiquinone, vegetable squalane and natural mixed extract, and method for preparing the same | |
KR102817536B1 (en) | Natural licorice extract with anti-inflammatory effect, centella asiatica extract and plant-based squalane complex cosmetic composition with moisturizing effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20201116 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20221126 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20230421 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20230425 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20230426 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |